Popowska Monika, Popowska Ludmila, Balashevich Leonid I, Szaflik Jacek P, Łazicka-Gałecka Monika
SPKSO Ophthalmic University Hospital Warsaw, 03-709 Warsaw, Poland.
LUMED Clinic, 26-300 Opoczno, Poland.
J Clin Med. 2025 Jul 29;14(15):5358. doi: 10.3390/jcm14155358.
Surgical management of large full-thickness macular holes (MHs) remains challenging, particularly when aiming for both rapid visual recovery and consistent anatomical closure without inducing retinal trauma. This retrospective single-center study evaluated the efficacy of activated conditioned plasma (ACP) as an intraoperative coadjuvant supporting ILM (internal limiting membrane) peeling and air tamponade in the treatment of idiopathic MHs measuring 400-800 µm, under real-time intraoperative optical coherence tomography (i-OCT) guidance. Seventy eyes from fifty patients underwent pars plana vitrectomy with intraoperative ACP application. ACP, a leukocyte-poor autologous platelet concentrate, was used intraoperatively as a coadjuvant to ILM peeling and air tamponade. It facilitated the formation of a transparent fibrin membrane over the retinal surface, supporting edge approximation and promoting retinal healing. The primary outcome was complete MH closure confirmed by OCT; the secondary outcome was improvement in BCVA on postoperative day 7 and during a 12-month follow-up. Anatomical closure was achieved in 98.6% of cases. On day 7, 78.6% of eyes showed a ≥ three-line BCVA improvement, with mean BCVA increasing from 0.25 ± 0.21 to 0.69 ± 0.20 ( < 0.001). These outcomes remained stable throughout the follow-up. No significant intraoperative or postoperative complications were observed. The combination of ACP and i-OCT appears to be a safe and effective strategy for anatomical foveolar reconstruction, enabling early visual recovery while minimizing inflammation and fibrotic scarring associated with conventional techniques.
大型全层黄斑裂孔(MHs)的手术治疗仍然具有挑战性,尤其是在既要实现快速视力恢复又要实现一致的解剖学闭合且不引起视网膜创伤的情况下。这项回顾性单中心研究评估了活化条件血浆(ACP)作为术中辅助剂支持内界膜(ILM)剥除和空气填塞在治疗直径为400 - 800 µm的特发性MHs中的疗效,该研究在术中实时光学相干断层扫描(i - OCT)引导下进行。五十名患者的七十只眼睛接受了玻璃体切除术并在术中应用了ACP。ACP是一种贫白细胞的自体血小板浓缩物,术中用作ILM剥除和空气填塞的辅助剂。它有助于在视网膜表面形成透明的纤维蛋白膜,支持边缘贴合并促进视网膜愈合。主要结局是通过OCT确认的MH完全闭合;次要结局是术后第7天以及12个月随访期间最佳矫正视力(BCVA)的改善。98.6%的病例实现了解剖学闭合。在第7天,78.6%的眼睛BCVA提高了≥3行,平均BCVA从0.25±0.21提高到0.69±0.20(<0.001)。这些结果在整个随访期间保持稳定。未观察到明显的术中或术后并发症。ACP和i - OCT的联合应用似乎是一种安全有效的解剖学黄斑中心凹重建策略,能够实现早期视力恢复,同时将与传统技术相关的炎症和纤维化瘢痕形成降至最低。